These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35340926)

  • 1. The transformation of non-ICU into ICU facilities may compromise patient safety in terms of infections.
    Iordanou S
    J Infect Prev; 2022 Mar; 23(2):79-80. PubMed ID: 35340926
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
    Rhomberg PR; Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evaluation of Risk Factors for Vancomycin-Resistant Enterococcus Colonization and Infection Among Mixed Adult Intensive Care Unit Patients.
    Doganci M; Izdes S; Cirik MO
    Cureus; 2023 Jan; 15(1):e33210. PubMed ID: 36733561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals.
    Monnet DL; Archibald LK; Phillips L; Tenover FC; McGowan JE; Gaynes RP
    Infect Control Hosp Epidemiol; 1998 Jun; 19(6):388-94. PubMed ID: 9669619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial use and susceptibility rates in isolates from intensive care unit and other nosocomial inpatient and outpatient areas.
    Lang A; De Fina G; Meyer R; Aschbacher R; Zelger P; Paluselli P; Rizza F
    New Microbiol; 2001 Jan; 24(1):47-56. PubMed ID: 11209842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the National Healthcare Safety Network standardized infection ratio risk adjustment for healthcare-facility-onset
    Polage CR; Quan KA; Madey K; Myers FE; Wightman DA; Krishna S; Grein JD; Gibbs L; Yokoe D; Mabalot SC; Chinn R; Hallmark A; Rubin Z; Fontenot M; Cohen S; Birnbaum D; Huang SS; Torriani FJ
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):404-410. PubMed ID: 32052726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):443-8. PubMed ID: 24492025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance in the intensive care unit: impact of new patterns.
    McGowan J; Tenover F
    Int J Clin Pract Suppl; 1998 Jun; 95():14-22. PubMed ID: 9796551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids.
    Patwardhan RB; Dhakephalkar PK; Niphadkar KB; Chopade BA
    Indian J Med Res; 2008 Aug; 128(2):178-87. PubMed ID: 19001682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2-Year Single-Centre Audit on Antibiotic Resistance of
    Feretzakis G; Loupelis E; Sakagianni A; Skarmoutsou N; Michelidou S; Velentza A; Martsoukou M; Valakis K; Petropoulou S; Koutalas E
    Antibiotics (Basel); 2019 May; 8(2):. PubMed ID: 31096587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial prescription in severe COVID-19 and CAP: a matched case-control study.
    Fierens J; De Bus L; Colpaert K; Boelens J; Gadeyne B; Decruyenaere J; Van Braeckel E; Depuydt P
    Acta Clin Belg; 2022 Oct; 77(5):837-844. PubMed ID: 34709997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surviving Sepsis in the Intensive Care Unit: The Challenge of Antimicrobial Resistance and the Trauma Patient.
    Ramsamy Y; Hardcastle TC; Muckart DJJ
    World J Surg; 2017 May; 41(5):1165-1169. PubMed ID: 27146052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing prevalence of antimicrobial resistance in intensive care units.
    Fridkin SK
    Crit Care Med; 2001 Apr; 29(4 Suppl):N64-8. PubMed ID: 11292878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained multimodal antimicrobial stewardship in an Australian tertiary intensive care unit from 2008-2015: an interrupted time-series analysis.
    Adhikari S; Piza M; Taylor P; Deshpande K; Lam D; Konecny P
    Int J Antimicrob Agents; 2018 Apr; 51(4):620-628. PubMed ID: 29410029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
    Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
    Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between antibiotic resistance in intensive care unit (ICU)-acquired infections and excess resource utilization: Evidence from Spain, Italy, and Portugal.
    Serra-Burriel M; Campillo-Artero C; Agodi A; Barchitta M; López-Casasnovas G
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1360-1367. PubMed ID: 34657648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of antimicrobial resistance on long-term mortality and quality of life in critically ill patients: a prospective longitudinal 2-year study.
    Koukoubani T; Makris D; Daniil Z; Paraforou T; Tsolaki V; Zakynthinos E; Papanikolaou J
    Health Qual Life Outcomes; 2021 Mar; 19(1):72. PubMed ID: 33658021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.
    Adrie C; Garrouste-Orgeas M; Ibn Essaied W; Schwebel C; Darmon M; Mourvillier B; Ruckly S; Dumenil AS; Kallel H; Argaud L; Marcotte G; Barbier F; Laurent V; Goldgran-Toledano D; Clec'h C; Azoulay E; Souweine B; Timsit JF;
    J Infect; 2017 Feb; 74(2):131-141. PubMed ID: 27838521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.